Skip to main content
AGPU logo
AGPU
(NASDAQ)
Axe Compute Inc.
$7.36-- (--)
Loading... - Market loading

Axe Compute (AGPU) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Axe Compute Inc.
AGPUNasdaq Stock MarketTechnologySoftware - Infrastructure

About Axe Compute

Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Discovery Services segment engages in the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone412 432 1500
Address
91 43rd Street, Suite 110 Pittsburgh, Pennsylvania 15201 United States

Corporate Identifiers

CIK0001446159
CUSIP74039M408
ISINUS74039M4087

Leadership Team & Key Executives

Christopher Miglino
Chief Executive Officer and Director
Kyle Okamoto
President
Jeremy Yaukey-Witter
Chief Financial Officer
Erin McMahon
Vice President of Marketing and Investor Relations
Sara Turken J.D.
General Counsel
Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.
Senior Vice President of Biologics
Dr. Arlette H. Uihlein FCAP, M.D.
Senior Vice President of Translational Medicine and Drug Discovery and Medical Director